CytomX Therapeutics Inc (CTMX)

1.13 +0.07 (+6.60%) USD  |  NASDAQ  |  Jan 03, 16:00
1.13 0.00 (0.00%) After-Hours: 06:09
More

CytomX Therapeutics Research and Development Expense (Annual): 77.68M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for CTMX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Spero Therapeutics Inc 51.44M
Castle Biosciences Inc 53.62M
Verastem Inc 61.36M
Arcutis Biotherapeutics Inc 110.58M
NovaBay Pharmaceuticals Inc 0.068M